Edition 12 of the Complex Lipid Management Self-Assessment Program (CLM-SAP) is a clinical problem-solving, evidence-based CME program of active engagement. It is also accredited for allied health professionals. It is designed to objectively assess and strengthen your knowledge of lipid disorders and provide you with a better understanding of the options available for managing patients with dyslipidemia. You can complete this program at your own pace, whenever and wherever you choose.

CLM-SAP Edition 12 will be available to purchase in November 2008 in
2 convenient formats

 Downloadable PDF.
 Print version.

Educational Objectives

 Outline HDL metabolism and potential therapeutic targets.

 Describe the role of HDL in atherogenesis.

 Review the development of therapies designed to improve
 reverse cholesterol transport.

 Identify HDL mimetics and analyze their potential role in
 reversing atherosclerosis.

 Explain the principles of modifying anti-inflammatory properties
 of HDL.

 Review ongoing clinical trials to assess the effects of modifying
 HDL on atherosclerosis.

Back to Complex Lipid Management